2H-1,5-Benzodioxepin-3(4H)-one, 7-(3-methylbutyl)-
Common Name: |
2H-1,5-Benzodioxepin-3(4H)-one, 7-(3-methylbutyl)- |
IUPAC Name: |
7-(3-methylbutyl)-1,5-benzodioxepin-3-one |
Molecular Formula: |
C14H18O3 |
SMILES: |
CC(C)CCC1=CC2=C(C=C1)OCC(=O)CO2 |
Inchi: |
1S/C14H18O3/c1-10(2)3-4-11-5-6-13-14(7-11)17-9-12(15)8-16-13/h5-7,10H,3-4,8-9H2,1-2H3 |
Inchi Key: |
AWAHFLZWCBUHMX-UHFFFAOYSA-N |
Cas No: |
362467-67-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
234.29 |
Mass (g/mol) |
234.126 |
Molar Refractivity |
66.51 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
3 |
Rings |
2 |
TPSA |
35.53 |
Hetero Atoms |
3 |
Heavy Atoms |
17 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
349.21 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.50 |
LogP |
2.616 |
iLOGP |
2.78 |
XLOGP3 |
3.64 |
WLOGP |
2.62 |
MLOGP |
1.85 |
ESOL Log S |
-3.65 |
ESOL Solubility (mg/ml) |
0.053 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.07 |
Ali Solubility (mg/ml) |
0.02 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-4.24 |
Silicos-IT Solubility (mg/ml) |
0.01 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.14 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.499 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.25 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
1 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |